- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07756177
Guangzhou Preterm and Term Birth Cohort Study (GPTBC)
The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a prospective observational study of how early-life nutrition, environmental exposures, and family factors relate to the health and development of preterm and term infants and their mothers. Mother-infant pairs are followed from birth to 24 months. Researchers use questionnaires and biological samples to study human milk, microorganisms in the infant gut, physical growth, development, and allergic diseases, and whether these relationships differ between preterm and term infants. Findings may inform nutrition and health strategies for infants born at different gestational ages.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a single-center, prospective longitudinal observational study conducted at the Third Affiliated Hospital of Guangzhou Medical University. Mothers and their preterm or term infants were enrolled within 7 days after delivery and are followed primarily through 24 months of age; a subset receives additional follow-up beyond 24 months. The cohort was designed to recruit approximately equal numbers of preterm and term infants to characterize early-life exposures and health trajectories and to assess whether preterm birth modifies exposure-outcome associations.
The primary scientific focus is how human milk composition and other early-life nutritional and environmental exposures relate to infant growth, neuropsychological development, allergic diseases, and gut microbiome development. Serial human milk samples support measurements of nutritional components, 23 targeted human milk oligosaccharides, selected bioactive proteins, fatty acids, metabolomic and lipidomic profiles, microbial metagenomes, and exposomic profiles of environmental contaminants. Infant stool samples are analyzed using metagenomic sequencing. Additional stored biospecimens support related current and future research.
Repeated questionnaires capture maternal postpartum health, diet, lifestyle, psychological status, medication use, and breastfeeding; infant feeding, supplementation, illness, medication use, sleep, activity, screen exposure, and caregiving environment; and selected paternal and family characteristics. Child health is assessed longitudinally using anthropometry, standardized developmental assessments, eye tracking, parental reports of physician-diagnosed allergic diseases, and microbiome measures.
The study will examine exposure patterns and their changes over time, associations with maternal and child health, potential biological pathways, and differences between preterm and term infants.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienorte
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Sun Yat-sen University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Mother-infant pairs (term and preterm).
Beschreibung
Inclusion Criteria:
- Maternal age between 18 and 45 years.
- Resident in Guangzhou for at least one year.
- Gestational age at delivery ≥ 32 weeks and < 42 weeks (moderate-to-late preterm or term births).
Exclusion Criteria:
- Critical illness during pregnancy requiring admission to the intensive care unit.
- Unwilling or unable to breastfeed.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Preterm Birth Group
Mother-infant pairs in which the infant was born at 32 weeks 0 days to 36 weeks 6 days of gestation. |
This cohort study have any no intervention. |
|
Term Birth Group
Mother-infant pairs in which the infant was born at 37 weeks 0 days to 41 weeks 6 days of gestation. |
This cohort study have any no intervention. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Offspring Length/Height (cm)
Zeitfenster: Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
Offspring length or height measured by a pediatrician. |
Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
|
Offspring Weight (kg)
Zeitfenster: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Offspring weight measured using a calibrated scale. |
Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
|
Offspring Head Circumference (cm)
Zeitfenster: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Offspring head circumference measured by a pediatrician. |
Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
|
Offspring Body Mass Index (kg/m²)
Zeitfenster: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Calculated as weight (kg) divided by the square of length or height (in meters). |
Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
|
Neurodevelopmental outcome - Gesell Developmental Schedules (GDS)
Zeitfenster: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
Developmental Quotients (DQ) for each developmental domain, assessed by the Gesell Developmental Schedules (GDS) administered by a pediatrician. DQ is calculated as (developmental age / chronological age or corrected age) × 100, with higher DQ indicating better development. Domains include: (1) adaptive, (2) gross motor, (3) fine motor, (4) language, and (5) personal-social. |
1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
|
Neurodevelopmental outcome - Ages and Stages Questionnaires (ASQ)
Zeitfenster: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Parent-reported scores (0-60) for each developmental domain, assessed using the Ages and Stages Questionnaires (ASQ). Higher scores indicate better development. Domains include: (1) communication, (2) gross motor, (3) fine motor, (4) problem-solving, and (5) personal-social. |
1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Social Cognitive Attention Patterns - Sufficient Fixation Trials (number)
Zeitfenster: 6 months, 8 months, and 12 months of age.
|
Number of trials in which the fixation duration on specific Areas of Interest (social and non-social) exceeds 30% of the total fixation duration on the entire screen, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator indicates adequate attentional engagement with the presented social and non-social stimuli. |
6 months, 8 months, and 12 months of age.
|
|
Social Cognitive Attention Patterns - First Fixation Count (number)
Zeitfenster: 6 months, 8 months, 12 months of age.
|
Number of times the first fixation following stimuli onset lands on specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator captures initial attentional orienting and reflects the salience of the presented social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - First Fixation Duration (seconds)
Zeitfenster: 6 months, 8 months, 12 months of age.
|
Duration (in seconds) of the first fixation within specific Areas of Interest (social and non-social) following stimulus onset, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects early-stage attentional processing and the efficiency of initial stimulus engagement. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - Total Fixation Count (number)
Zeitfenster: 6 months, 8 months, 12 months of age.
|
Total number of discrete fixation events occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects the overall frequency of attentional engagement with the presented social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - Total Fixation Duration (seconds)
Zeitfenster: 6 months, 8 months, 12 months of age.
|
Cumulative duration (in seconds) of all fixations occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects overall attentional allocation to the presented social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - Fixation Duration Proportion (%)
Zeitfenster: 6 months, 8 months, 12 months of age.
|
Percentage of total fixation time allocated to social or non-social Areas of Interest, calculated as (total fixation time on social or non-social Areas of Interest / total fixation time on all Areas of Interest) × 100, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects relative attentional preference between social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Number of Participants with Physician-Diagnosed Allergic Diseases
Zeitfenster: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Number of participants who experience at least one episode of physician-diagnosed allergic diseases during the follow-up period, including eczema or atopic dermatitis, cow's milk protein allergy, other food allergies, allergic rhinitis, and asthma, as diagnosed by a physician and reported by parents, and confirmed by medical records. |
1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Li Cai, Ph.D, Sun Yat-sen University
- Hauptermittler: Lizi Lin, Ph.D, Sun Yat-sen University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
- Stoffwechsel
- Neuroentwicklung
- Soziale Wahrnehmung
- Frühgeburt
- Fettsäuren
- Visuelle Aufmerksamkeit
- Menschliche Milch-Oligosaccharide
- Termingerechte Geburt
- Osteopontin
- Wachstum und Entwicklung von Kindern
- Human Milk Composition
- Infant Gut Microbiome
- Human Milk Exposome
- Early-Life Nutrition
- Maternal Diet
Zusätzliche relevante MeSH-Bedingungen
- Urogenitale Erkrankungen
- Psychische Störungen
- Ernährungsstörungen
- Weibliche Urogenitalerkrankungen und Schwangerschaftskomplikationen
- Überernährung
- Körpergewicht
- Geburtshilfe, Frühgeburt
- Geburtsbedingte Geburtskomplikationen
- Schwangerschaftskomplikationen
- Pathologische Zustände, Anzeichen und Symptome
- Ernährungs- und Stoffwechselerkrankungen
- Anzeichen und Symptome
- Übergewicht
- Frühgeburt
- Fettleibigkeit
- Neuroentwicklungsstörungen
Andere Studien-ID-Nummern
- GPTBC
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .